Characteristic | Total N (%, 95 CI) | Males N (%, 95%, CI) | Females N (%, 95%, CI) | P-value |
- Diabetes | -
| -
| -
| -
|
Overall prevalence | 71 (11.7, 9.1 - 14.3) | 27 (14.1, 9.2 - 19.1) | 44 (10.6, 7.6 - 13.6) | 0.22 |
*Detected | 39 (54.9) | 10 (37) | 29 (65.9) | 0.02 |
Not Aware †Controlled Prevalence of diabetes in different groups Age group | 32 (45.1) 9 (28.1) | 17 (63) 5 (29.4) | 15 (34.1) 4 (26.7) | 0.02 0.06 |
20 - 29 30 - 39 40 - 49 50 - 59 ≥60 | 8 (5.8, 1.9 - 9.7) 11 (10.9, 4.8 - 17) 16 (13.1, 7.1 - 19.1) 15 (13.3, 7 - 19.6) 21 (16.2, 9.9 - 14.3) | 5 (14.3, 2.7 - 25.9) 1 (7.7, −6.8 - 22.2) 4 (13.3, 1.1 - 25.4) 6 (14.6, 3.8 - 25.4) 11 (15.3, 7 - 23.6) | 3 (2.9, −0.3 - 6.1) 10 (11.4, 4.8 - 18) 12 (13, 6.1 - 19.9) 9 (12.5, 4.9 - 20.1) 10 (17.2,7.5 - 26.9) | 0.02** 0.69 0.97 0.75 0.76 |
BMI category <18.5 18.5 - 24.9 25 - 29.9 ≥30 |
- 24 (8.4, 5.2 - 11.6) 34 (19.1, 13.3 - 24.9) 13 (11, 5.4 - 16.7) |
- 12 (10.6, 4.9 - 16.3) 10 (18.5, 8.2 - 28.9) 5 (33.3, 9.4 - 57.2) |
- 12 (7, 3.2 - 10.9) 24 (19.4, 12.4 - 26.3) 8 (7.8, 2.6 - 12.9) |
- 0.28 0.9 <0.01 |
Medical History Stroke Hypertension | - 3 (17.6, −0.5 - 35.8) 27 (8.5, 5.5 - 11.6) | - 1 (14.3, −11.6 - 40.2) 9 (9.9, 3.8 - 16) | - 2 (20, −4 - 44.8) 18 (8, 4.5 - 11.5) | - 0.1** 0.34 |